دورية أكاديمية

Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial

التفاصيل البيبلوغرافية
العنوان: Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial
المؤلفون: Coombs, J.H., Bloom, B.J., Breedveld, F.C., Fletcher, M.P., Gruben, D., Kremer, J.M., Burgos-Vargas, R., Wilkinson, B., Zerbini, C.A.F., Zwillich, S.H.
المصدر: Annals of the Rheumatic Diseases
سنة النشر: 2010
المجموعة: Leiden Repository (Leiden University)
مصطلحات موضوعية: quality-of-life combination therapy monoclonal-antibody reported outcomes methotrexate etanercept adalimumab efficacy safety
الوصف: Objectives: To determine the efficacy of CP-690,550 in improving pain, function and health status in patients with moderate to severe active rheumatoid arthritis (RA) and an inadequate response to methotrexate or a tumour necrosis factor a inhibitor. Methods: Patients were randomised equally to placebo, CP-690,550 5, 15 or 30 mg twice daily for 6 weeks, with 6 weeks' follow-up. The patient's assessment of arthritis pain (pain), patient's assessment of disease activity, Health Assessment Questionnaire-Disability Index (HAQ-DI) and Short Form-36 (SF-36) were recorded. Results: At week 6, significantly more patients in the CP-690,550 5, 15 and 30 mg twice-daily groups experienced a 50% improvement in pain compared with placebo (44%, 66%, 78% and 14%, respectively), clinically meaningful reductions in HAQ-DI (>= 0.3 units) (57%, 75%, 76% and 36%, respectively) and clinically meaningful improvements in SF-36 domains and physical and mental components. Conclusions: CP-690,550 was efficacious in improving the pain, function and health status of patients with RA, from week 1 to week 6. ; Pathophysiology and treatment of rheumatic diseases
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: lumc-id: 5605810; https://hdl.handle.net/1887/111426Test
الإتاحة: https://hdl.handle.net/1887/111426Test
رقم الانضمام: edsbas.41FC3BF4
قاعدة البيانات: BASE